Tesofensine (NS2330) is a Triple monoamine reuptake inhibitor (dopamine, noradrenaline, serotonin) researched for Weight Loss / Appetite Suppression Research, Monoamine Transporter Pharmacology, Neurodegeneration Research (Original Indication). QSC supplies Tesofensine to researchers across Nebraska with domestic USA shipping and Janoshik COA verification.
Tesofensine is a triple monoamine reuptake inhibitor (DA, NA, 5-HT) originally developed for Parkinson’s and Alzheimer’s disease before its potent weight-reducing effects were observed in clinical trials. Inhibits presynaptic dopamine, noradrenaline, and serotonin transporters — raising synaptic monoamine concentrations in reward, appetite, and thermogenesis… Full Tesofensine Research Hub →
